EMMI, GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 3.863
NA - Nord America 1.785
SA - Sud America 1.627
EU - Europa 1.285
AF - Africa 155
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.724
Nazione #
US - Stati Uniti d'America 1.617
BR - Brasile 1.296
SG - Singapore 1.233
CN - Cina 764
VN - Vietnam 649
HK - Hong Kong 602
IT - Italia 497
KR - Corea 204
NL - Olanda 156
AR - Argentina 127
RU - Federazione Russa 123
GB - Regno Unito 107
DE - Germania 93
MX - Messico 89
FR - Francia 88
IN - India 73
EC - Ecuador 66
ID - Indonesia 60
BD - Bangladesh 58
ZA - Sudafrica 47
CO - Colombia 46
CA - Canada 41
AT - Austria 37
MA - Marocco 36
SE - Svezia 36
PL - Polonia 34
FI - Finlandia 32
JP - Giappone 28
TR - Turchia 26
IQ - Iraq 25
PY - Paraguay 25
EG - Egitto 21
ES - Italia 20
CL - Cile 18
PE - Perù 17
UZ - Uzbekistan 15
BE - Belgio 14
IR - Iran 14
TN - Tunisia 14
UA - Ucraina 14
VE - Venezuela 14
PK - Pakistan 13
SA - Arabia Saudita 13
IL - Israele 12
UY - Uruguay 11
DZ - Algeria 10
AZ - Azerbaigian 9
DO - Repubblica Dominicana 9
IE - Irlanda 8
JM - Giamaica 7
KE - Kenya 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 4
BO - Bolivia 4
GE - Georgia 4
LT - Lituania 4
NP - Nepal 4
OM - Oman 4
PA - Panama 4
PT - Portogallo 4
TH - Thailandia 4
AO - Angola 3
BW - Botswana 3
CR - Costa Rica 3
ET - Etiopia 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
JO - Giordania 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PS - Palestinian Territory 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
CU - Cuba 1
GA - Gabon 1
GH - Ghana 1
Totale 8.710
Città #
Hong Kong 598
Hefei 522
Singapore 518
Boardman 252
Ho Chi Minh City 247
Ashburn 242
Seoul 204
Trieste 203
Hanoi 138
Los Angeles 131
Beijing 101
São Paulo 98
Chicago 60
Santa Clara 58
Buffalo 50
London 50
Dallas 45
Mexico City 44
Milan 40
Rio de Janeiro 40
Redondo Beach 37
New York 36
Moscow 35
Haiphong 34
Belo Horizonte 30
Salt Lake City 30
Da Nang 29
Rome 29
Ann Arbor 27
Fairfield 26
Casablanca 25
Guayaquil 24
Warsaw 24
Curitiba 23
Munich 23
Biên Hòa 22
Frankfurt am Main 22
Chandler 21
Woodbridge 21
Campinas 20
Porto Alegre 20
Tokyo 20
Brasília 19
Vienna 19
Nuremberg 17
Quito 17
Salvador 17
Thái Bình 17
Denver 16
Johannesburg 16
Turku 16
Houston 15
Tampa 15
Wilmington 15
Buenos Aires 14
Cape Town 14
Guarulhos 14
Menlo Park 14
Tashkent 14
Cairo 13
Dhaka 13
Genoa 13
Goiânia 13
Tehran 13
Turin 13
Amsterdam 12
Brussels 12
Elk Grove Village 12
Helsinki 12
Montreal 11
Ninh Bình 11
Santo André 11
Thái Nguyên 11
Brooklyn 10
Hortolândia 10
Orem 10
Recife 10
San Francisco 10
Stockholm 10
Baku 9
Belém 9
Bogotá 9
Bắc Giang 9
Delhi 9
Hải Dương 9
Mumbai 9
Phoenix 9
Seattle 9
Sterling 9
São Gonçalo 9
Atlanta 8
Canoas 8
Chennai 8
Düsseldorf 8
Itaquaquecetuba 8
Lauterbourg 8
Lima 8
Montevideo 8
Piracicaba 8
Poplar 8
Totale 4.897
Nome #
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 248
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 219
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 178
Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach 162
Infliximab and Cogan's syndrome 142
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies 130
PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis 129
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 104
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 99
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 96
Vascular Behçet syndrome: from pathogenesis to treatment 94
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 85
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study 78
Serum IgG2 antibody multi-composition in Systemic Lupus Erythematosus and in Lupus nephritis (Part 2). Prospective study 77
Presentation and progression of MPO-ANCA interstitial lung disease 77
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 76
Advancing Thrombosis Research: A Novel Device for Measuring Clot Permeability 73
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 70
Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology 70
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 69
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 68
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 67
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors 67
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis 66
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort 65
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 64
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis 63
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 62
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 62
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 60
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries 59
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 59
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 59
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 59
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 58
A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility 58
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 57
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 56
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 55
Development and implementation of the AIDA International Registry for patients with Behçet's disease 55
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement 54
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 53
Biologics for eosinophilic granulomatosis with polyangiitis 53
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome 53
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 52
Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors 52
Blood Leukocyte ROS Production Reflects Seminal Fluid Oxidative Stress and Spermatozoa Dysfunction in Idiopathic Infertile Men 52
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children 51
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry 51
Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response 50
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 50
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 50
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 50
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 49
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases 49
Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 49
Behçet's syndrome patients exhibit specific microbiome signature 48
Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation 48
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 48
Sjögren’s syndrome: a systemic autoimmune disease 47
Therapeutic approach to central nervous system involvement of Behçet's disease 47
The impact of environmental factors on aetiopathogenesis and clinical manifestations of Behçet's syndrome 47
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 46
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 46
Neutrophil Extracellular Traps in the Autoimmunity Context 46
Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectives 45
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 45
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry 45
A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions 45
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 45
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 45
Evidence for charge-based mimicry in anti dsDNA antibody generation 45
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 44
Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis 44
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 44
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy 44
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 43
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 43
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 43
Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet's syndrome 43
298. RITUXIMAB FOR DIFFICULT-TO-TREAT CHRONIC PARIAORTITIS: A CASE-SERIES OF 20 PATIENTS 43
Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients 43
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 42
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 42
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report 42
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 41
Comment on: Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. Reply 41
A multicenter approach to evaluate omalizumab effectiveness in Samter's triad 41
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 41
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 41
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 41
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 41
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 41
Effectiveness and safety of intravenous immunoglobulin for peripheral neuropathy in EGPA patients: a retrospective study 40
Microbiome in Behcet's syndrome 40
Pharmacological interventions for the prevention of fetal growth restriction: a systematic review and network meta-analysis 40
Adalimumab effectiveness in Behçetâ s disease: short and long-term data from a multicenter retrospective observational study 40
In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study 40
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 40
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis 40
Totale 6.219
Categoria #
all - tutte 29.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 11 1 5 6 4 3
2021/202246 5 1 0 8 0 4 3 0 7 4 2 12
2022/202364 7 12 4 8 11 9 0 3 5 2 2 1
2023/2024269 6 11 4 4 13 4 20 11 1 164 11 20
2024/20252.803 27 45 91 42 422 412 272 145 97 275 247 728
2025/20265.989 1.019 1.138 1.280 1.749 586 217 0 0 0 0 0 0
Totale 9.337